Meghan O'Neill

Meghan O'Neill is an experienced regulatory affairs professional with a comprehensive background in the pharmaceutical industry. Currently serving as the Executive Director of Regulatory Affairs and Program Management at Arthrosi Therapeutics, Inc. since January 2022, Meghan has held various leadership roles including Senior Director and Director of Regulatory Affairs at Evofem Biosciences and Associate Director of Regulatory Affairs at Greenwich Biosciences. Prior experience includes positions at TRACON Pharmaceuticals and multiple roles at Ardea Biosciences, Inc., where expertise spanned from regulatory project management to senior regulatory affairs associate roles. Meghan's educational background includes a degree from Boston University and further training at UC San Diego.